Human Umbilical Cord Matrix Stem Cells Maintain Multilineage Differentiation Abilities and Do Not Transform during Long-Term Culture

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Scheers, Isabelle ^a   Lombard, Catherine ^a   Paganelli, Massimiliano ^a   Campard, David ^a   Najimi, Mustapha ^a   Gala, Jean Luc ^a   Decottignies, Anabelle ^b   Sokal, Etienne ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b DE DUVE INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL AGING; CELL CULTURE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL EXPANSION; CELL GROWTH; CELL ISOLATION; CHROMOSOMAL INSTABILITY; CHROMOSOME ABERRATION; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; ENDODERM; GENE EXPRESSION; GENE FREQUENCY; GENOMIC INSTABILITY; HETEROZYGOSITY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; KARYOTYPING; LIVER CELL; MESODERM; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE C MYC; OSTEOCYTE; PHENOTYPE; TELOMERE; TP53 GENE; UMBILICAL CORD MATRIX STEM CELL TRANSPLANTATION; UPREGULATION;

EID: 84881226265     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071374     Document Type: Article

References (57)

1. Sancho-Bru P, Najimi M, Caruso M, Pauwelyn K, Cantz T, et al. (2009) Stem and progenitor cells for liver repopulation: can we standardise the process from bench to bedside? Gut 58: 594-603.
2. Nussler A, Konig S, Ott M, Sokal E, Christ B, et al. (2006) Present status and perspectives of cell-based therapies for liver diseases. J Hepatol 45: 144-159.
3. Sarugaser R, Lickorish D, Baksh D, Hosseini MM, Davies JE, (2005) Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 23: 220-229.
4. Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, et al. (2004) Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 22: 1330-1337.
5. Fu YS, Shih YT, Cheng YC, Min MY, (2004) Transformation of human umbilical mesenchymal cells into neurons in vitro. J Biomed Sci 11: 652-660.
6. Campard D, Lysy PA, Najimi M, Sokal EM, (2008) Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells. Gastroenterology 134: 833-848.
7. Scheers I, (2011) Cell therapy for the treatment of metabolic liver disease: an update on the umbilical cord derived stem cells candidates. Open Tissue Eng Regen Med J 4: 48-53.
8. Weiss ML, Anderson C, Medicetty S, Seshareddy KB, Weiss RJ, et al. (2008) Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells 26: 2865-2874.
9. Scheers I, Maerckx C, Khuu DN, Marcelle S, Decottignies A, et al. (2012) Adult derived human liver progenitor cells in long term culture maintain appropriate gatekeeper mechanisms against transformation. Cell Transplant.
10. Sherr CJ, DePinho RA, (2000) Cellular senescence: mitotic clock or culture shock? Cell 102: 407-410.
11. Miura M, Miura Y, Padilla-Nash HM, Molinolo AA, Fu B, et al. (2006) Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells 24: 1095-1103.
12. Tolar J, Nauta AJ, Osborn MJ, Panoskaltsis Mortari A, McElmurry RT, et al. (2007) Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 25: 371-379.
13. Wang Y, Huso DL, Harrington J, Kellner J, Jeong DK, et al. (2005) Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture. Cytotherapy 7: 509-519.
14. de la Fuente R, Bernad A, Garcia-Castro J, Martin MC, Cigudosa JC, (2010) Retraction: Spontaneous human adult stem cell transformation. Cancer Res 70: 6682.
15. Torsvik A, Rosland GV, Svendsen A, Molven A, Immervoll H, et al. (2010) Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track- letter. Cancer Res 70: 6393-6396.
16. Shiras A, Chettiar ST, Shepal V, Rajendran G, Prasad GR, et al. (2007) Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma. Stem Cells 25: 1478-1489.
17. Izadpanah R, Kaushal D, Kriedt C, Tsien F, Patel B, et al. (2008) Long-term in vitro expansion alters the biology of adult mesenchymal stem cells. Cancer Res 68: 4229-4238.
18. Fridman AL, Tainsky MA, (2008) Critical pathways in cellular senescence and immortalization revealed by gene expression profiling. Oncogene 27: 5975-5987.
19. Cho PS, Messina DJ, Hirsh EL, Chi N, Goldman SN, et al. (2008) Immunogenicity of umbilical cord tissue derived cells. Blood 111: 430-438.
20. Najimi M, Khuu DN, Lysy PA, Jazouli N, Abarca J, et al. (2007) Adult-derived human liver mesenchymal-like cells as a potential progenitor reservoir of hepatocytes? Cell Transplant 16: 717-728.
21. Suram A, Kaplunov J, Patel PL, Ruan H, Cerutti A, et al. (2012) Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions. EMBO J 31: 2839-2851.
22. Bajpai VK, Mistriotis P, Andreadis ST, (2012) Clonal multipotency and effect of long-term in vitro expansion on differentiation potential of human hair follicle derived mesenchymal stem cells. Stem Cell Res 8: 74-84.
23. Itahana K, Campisi J, Dimri GP, (2007) Methods to detect biomarkers of cellular senescence: the senescence-associated beta-galactosidase assay. Methods Mol Biol 371: 21-31.
24. Jiang XR, Jimenez G, Chang E, Frolkis M, Kusler B, et al. (1999) Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Genet 21: 111-114.
25. Tilman G, Loriot A, Van Beneden A, Arnoult N, Londono-Vallejo JA, et al. (2009) Subtelomeric DNA hypomethylation is not required for telomeric sister chromatid exchanges in ALT cells. Oncogene 28: 1682-1693.
26. Dekairelle AF, Tombal B, Cosyns JP, Gala JL, (2005) Assessment of the transcriptional activity of p53 improves the prediction of recurrence in superficial transitional cell carcinoma of the bladder. Clin Cancer Res 11: 4724-4732.
27. Waridel F, Estreicher A, Bron L, Flaman JM, Fontolliet C, et al. (1997) Field cancerisation and polyclonal p53 mutation in the upper aero-digestive tract. Oncogene 14: 163-169.
28. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, et al. (1997) Telomerase catalytic subunit homologs from fission yeast and human. Science 277: 955-959.
29. Shaffer SML, Campbell LJ, editor (2009) International System for Human Cytogenetic Nomenclature. Basel: Karger.
30. Hayflick L, (1965) The Limited in Vitro Lifetime of Human Diploid Cell Strains. Exp Cell Res 37: 614-636.
31. Wagner W, Horn P, Castoldi M, Diehlmann A, Bork S, et al. (2008) Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One 3: e2213.
32. Bonab MM, Alimoghaddam K, Talebian F, Ghaffari SH, Ghavamzadeh A, et al. (2006) Aging of mesenchymal stem cell in vitro. BMC Cell Biol 7: 14.
33. Finkel T, Serrano M, Blasco MA, (2007) The common biology of cancer and ageing. Nature 448: 767-774.
34. Rubio R, Garcia-Castro J, Gutierrez-Aranda I, Paramio J, Santos M, et al. (2010) Deficiency in p53 but not retinoblastoma induces the transformation of mesenchymal stem cells in vitro and initiates leiomyosarcoma in vivo. Cancer Res 70: 4185-4194.
35. Armesilla-Diaz A, Elvira G, Silva A, (2009) p53 regulates the proliferation, differentiation and spontaneous transformation of mesenchymal stem cells. Exp Cell Res 315: 3598-3610.
36. Petitjean A, Achatz MI, Borresen-Dale AL, Hainaut P, Olivier M, (2007) TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene 26: 2157-2165.
37. Lang GA, Iwakuma T, Suh YA, Liu G, Rao VA, et al. (2004) Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. Cell 119: 861-872.
38. Olive KP, Tuveson DA, Ruhe ZC, Yin B, Willis NA, et al. (2004) Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell 119: 847-860.
39. Brosh R, Rotter V, (2009) When mutants gain new powers: news from the mutant p53 field. Nat Rev Cancer 9: 701-713.
40. Eicheler W, Zips D, Dorfler A, Grenman R, Baumann M, (2002) Splicing mutations in TP53 in human squamous cell carcinoma lines influence immunohistochemical detection. J Histochem Cytochem 50: 197-204.
41. Anzalone R, Lo Iacono M, Corrao S, Magno F, Loria T, et al. (2010) New emerging potentials for human Wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity. Stem Cells Dev 19: 423-438.
42. Majore I, Moretti P, Hass R, Kasper C, (2009) Identification of subpopulations in mesenchymal stem cell-like cultures from human umbilical cord. Cell Commun Signal 7: 6.
43. Karahuseyinoglu S, Cinar O, Kilic E, Kara F, Akay GG, et al. (2007) Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells 25: 319-331.
44. Bernardo ME, Zaffaroni N, Novara F, Cometa AM, Avanzini MA, et al. (2007) Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 67: 9142-9149.
45. Ben-Porath I, Weinberg RA, (2004) When cells get stressed: an integrative view of cellular senescence. J Clin Invest 113: 8-13.
46. Banfi A, Muraglia A, Dozin B, Mastrogiacomo M, Cancedda R, et al. (2000) Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy. Exp Hematol 28: 707-715.
47. Mareschi K, Ferrero I, Rustichelli D, Aschero S, Gammaitoni L, et al. (2006) Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow. J Cell Biochem 97: 744-754.
48. Meza-Zepeda LA, Noer A, Dahl JA, Micci F, Myklebost O, et al. (2008) High-resolution analysis of genetic stability of human adipose tissue stem cells cultured to senescence. J Cell Mol Med 12: 553-563.
49. Tarte K, Gaillard J, Lataillade JJ, Fouillard L, Becker M, et al. (2010) Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood 115: 1549-1553.
50. Rosland GV, Svendsen A, Torsvik A, Sobala E, McCormack E, et al. (2009) Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res 69: 5331-5339.
51. Rubio D, Garcia-Castro J, Martin MC, de la Fuente R, Cigudosa JC, et al. (2005) Spontaneous human adult stem cell transformation. Cancer Res 65: 3035-3039.
52. Hahn WC, Weinberg RA, (2002) Rules for making human tumor cells. N Engl J Med 347: 1593-1603.
53. Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR, (1998) Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res 58: 4168-4172.
54. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR, (1997) Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 3: 1271-1274.
55. Sawada R, Ito T, Tsuchiya T, (2006) Changes in expression of genes related to cell proliferation in human mesenchymal stem cells during in vitro culture in comparison with cancer cells. J Artif Organs 9: 179-184.
56. Soucek T, Pusch O, Hengstschlager-Ottnad E, Wawra E, Bernaschek G, et al. (1995) Expression of the cyclin-dependent kinase inhibitor p16 during the ongoing cell cycle. FEBS Lett 373: 164-169.
57. Shay JW, Pereira-Smith OM, Wright WE, (1991) A role for both RB and p53 in the regulation of human cellular senescence. Exp Cell Res 196: 33-39.